Jeena Sikho Lifecare has formally executed the Room Block & Services Licence Agreement for its integrated wellness centre in Manali, Himachal Pradesh, on August 5, 2026. The deal, valued at ₹7.66 crore plus applicable taxes, was approved by the Board of Directors on August 4, 2026, and signed with Mr. Anil Saklani, owner of Ajna Resorts. This execution confirms the company’s expansion into premium wellness hospitality without capital expenditure on property acquisition.

The agreement grants Jeena Sikho Lifecare operational rights over thirty luxury guest rooms, five consultation/treatment rooms, and five exclusive spa treatment rooms at Ajna Resorts in Village Jagatsukh. Operations are scheduled to commence within 60 days of the Effective Date, subject to Commercial Readiness requirements. The transaction is classified as being in the ordinary course of business and is not a related party transaction.

Key Terms of the Executed Agreement

The licence term is set for eleven months from the Commercial Readiness Date. The fee structure requires two equal advance instalments paid at six-month intervals during each Contract Year. Financing will be sourced through internal accruals.

Strategic Impact on Infrastructure

This capacity addition strengthens Jeena Sikho Lifecare’s integrated healthcare offerings by entering the premium wellness retreat market. The company currently operates over 120 Ayurveda clinics and hospitals. The Manali centre will serve as a dedicated hub for health transformation programmes, leveraging the resort’s existing infrastructure. By utilising a licence model, the company avoids heavy capex while rapidly scaling its service footprint in a high-demand tourist destination.

Regulatory disclosures were made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The details have been uploaded to the company’s website for stakeholder reference.

Jeena Sikho Lifecare Limited expanded its healthcare and wellness portfolio by launching Amrit Dhara Drops 20 ml on August 4, 2026. The new Ayurvedic product is designed for the domestic market and focuses on managing cold and cough symptoms using traditionally used herbs. This launch reinforces the company’s presence in the herbal remedies segment, adding to its existing network of over 120 Ayurveda clinics and hospitals.

The company disclosed the launch under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made in compliance with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The information was submitted to both the National Stock Exchange of India Limited and BSE Limited.

Product Details

The key specifications of the newly launched product are outlined below:

Manish Grover, Managing Director of Jeena Sikho Lifecare Limited, signed the intimation filed with the stock exchanges. The company operates from its registered office in Zirakpur, Punjab, and its corporate office in New Multan Nagar, Delhi.

Strategic Context

The introduction of Amrit Dhara Drops aligns with Jeena Sikho Lifecare’s broader strategy to offer drug-free solutions for common ailments. By targeting the domestic market with a specialized formulation for cold and cough, the company aims to deepen its penetration in the consumer-facing Ayurvedic sector. The product packaging highlights traditional herbs, emphasizing the natural composition of the drops.

This expansion adds a new SKU to the company’s offerings without entering international markets at this stage. The focus remains on leveraging the company’s extensive clinic network to drive awareness and sales within India.